Last reviewed · How we verify
Chronic sinusitis
Approved treatments
- Dupixent · Regeneron
Dupixent blocks the interleukin-4 receptor, a key player in the immune system's inflammatory response.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic sinusitis patent landscape — cliff calendar, originator estates, attackable patents
- Chronic sinusitis treatment landscape brief
- Chronic sinusitis treatment updates RSS
Frequently asked questions about Chronic sinusitis
What drugs treat Chronic sinusitis?
Tracked treatments include Dupixent.
What is the treatment for Chronic sinusitis?
Standard treatment for Chronic sinusitis includes Dupixent. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic sinusitis patent cliff · Chronic sinusitis CI report
- Treatment: Dupixent · Regeneron
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing